MAM
McLean Asset Management’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Buy |
1,495
+4
| +0.3% | +$3.12K | 0.31% | 43 |
|
|
2025
Q1 | $1.08M | Buy |
1,491
+29
| +2% | +$21.1K | 0.36% | 40 |
|
|
2024
Q4 | $1.13M | Sell |
1,462
-284
| -16% | -$219K | 0.34% | 40 |
|
|
2024
Q3 | $1.55M | Buy |
1,746
+270
| +18% | +$239K | 0.47% | 33 |
|
|
2024
Q2 | $1.39M | Buy |
1,476
+39
| +3% | +$36.6K | 0.45% | 35 |
|
|
2024
Q1 | $1.09M | Buy |
1,437
+1
| +0.1% | +$757 | 0.37% | 38 |
|
|
2023
Q4 | $888K | Sell |
1,436
-3
| -0.2% | -$1.86K | 0.33% | 40 |
|
|
2023
Q3 | $833K | Hold |
1,439
| – | – | 0.34% | 40 |
|
|
2023
Q2 | $675K | Buy |
1,439
+26
| +2% | +$12.2K | 0.26% | 50 |
|
|
2023
Q1 | $485K | Sell |
1,413
-183
| -11% | -$62.9K | 0.2% | 59 |
|
|
2022
Q4 | $584K | Buy |
1,596
+96
| +6% | +$35.1K | 0.2% | 57 |
|
|
2022
Q3 | $490K | Buy |
1,500
+31
| +2% | +$10.1K | 0.19% | 59 |
|
|
2022
Q2 | $485K | Buy |
1,469
+64
| +5% | +$21.1K | 0.19% | 57 |
|
|
2022
Q1 | $402K | Buy |
1,405
+33
| +2% | +$9.44K | 0.3% | 62 |
|
|
2021
Q4 | $351K | Sell |
1,372
-2
| -0.1% | -$512 | 0.14% | 77 |
|
|
2021
Q3 | $341K | Buy |
1,374
+149
| +12% | +$37K | 0.13% | 83 |
|
|
2021
Q2 | $285K | Buy |
1,225
+95
| +8% | +$22.1K | 0.13% | 81 |
|
|
2021
Q1 | $206K | Buy |
+1,130
| New | +$206K | 0.16% | 100 |
|